Stephen A. Hill, Director at Cellectar Biosciences, Inc. (CLRB), bought 5,300 shares at $3.75 ($20K) on 2014-08-20, disclosed to the SEC on 2014-08-22.
Open-market purchase of $20k CLRB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| LPCN | SELL | 2018-01-02 | $4K | — | Filing → |
| CLRB | BUY | 2016-04-21 | $20K | — | Filing → |
| CBIO | BUY | 2015-12-18 | $10K | — | Filing → |